(Q42795828)
Statements
1 reference
The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity (English)
1 reference
A E Dear
1 reference
R L Medcalf
1 reference
1 June 2000
1 reference
1 reference
Identifiers
1 reference